Ya desde los 25 años: el movimiento excepcional para la lucha contra el cáncer de mama en Israel
Aproximadamente 1.2 millones de aseguradas de Clalit entre las edades de 25 y 74 recibirán un contacto digital para evaluar su riesgo personal de desarrollar cáncer de mama, y el seguimiento se adaptará a cada…
Valoración
Clalit Health Services is launching a digital risk assessment for breast cancer for 1.2 million female members aged 25 to 74, a significant departure from standard screening protocols that begin mammograms only at age 50. The move acknowledges that about a quarter of breast cancer patients are under 50, yet current public funding leaves younger women without routine screening. This proactive outreach, described by the nonprofit One in Nine as unprecedented in scope, could shift how early detection is managed in Israel. The key question is whether the risk assessments will lead to actionable follow up and whether other health funds will adopt similar models.